A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis

Autoimmune Disorder
Multiple Sclerosis (MS)

Results
Download

Study results

LPS CN41144 OCARINA I Interim Results December 2024 English (PDF, 0.4 MB)

LPS CN41144 Final Results May 2026 English (PDF, 0.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis

Study results

LPS CN41144 OCARINA I Interim Results December 2024 English (PDF, 0.4 MB)

LPS CN41144 Final Results May 2026 English (PDF, 0.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis

For the latest version of this information please go to www.forpatients.roche.com